Want to see CDLX full AI Analyst Report?
CDLX Stock Chart & Stats
$4.13
$0.12(3.31%)
At close: 4:00 PM EDT
$4.13
$0.12(3.31%)
Day’s Range― - ―
52-Week Range$1.67 - $21.70
Previous Close$3.74
Volume45.72K
Average Volume (3M)64.88K
Market Cap
$10.66M
Enterprise Value$187.71M
Total Cash (Recent Filing)$28.04M
Total Debt (Recent Filing)$189.89M
Price to Earnings (P/E)―
Beta2.38
Next Earnings
Nov 11, 2026EPS Estimate
-1.93Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.58
Shares Outstanding5,888,716
10 Day Avg. Volume99,497
30 Day Avg. Volume64,881
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-9.39
Price to Sales (P/S)0.26
P/FCF Ratio-9.41
Enterprise Value/Market Cap17.61
Enterprise Value/Revenue1.05
Enterprise Value/Gross Profit2.18
Enterprise Value/Ebitda-2.69
Forecast
1Y Price Target
$5.00Price Target Upside21.07% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)-4.6
Revenue Forecast (FY)$147.77M
Bulls Say, Bears Say
Bulls Say
Advertiser Growth And RetentionExpanding advertiser activity alongside sharply improved retention strengthens the platform’s recurring demand profile. Better measurement and easier campaign scaling can support renewals, improve sales efficiency, and make Cardlytics more durable as it rebuilds campaign volume.
AI-enabled Operating EfficiencyThe AI-forward technology stack can increase campaign throughput without equivalent headcount growth, improving scalability in the core advertising workflow. Faster execution and richer spending insights may also strengthen advertiser value and support more efficient future growth.
Cost Discipline And Contribution MarginLower operating expenses and improved contribution margin show meaningful progress toward a more sustainable cost structure. If maintained, this discipline can help the company convert stabilization in billings into positive adjusted EBITDA and reduce the spending needed to support operations.
Bears Say
Persistent Revenue And Billings DeclineThe steep top-line contraction indicates that Cardlytics has not yet restored the scale lost after bank partner relationship changes. Prolonged revenue pressure can weaken operating leverage, limit investment capacity, and make recent efficiency gains harder to translate into durable earnings.
Ongoing Cash Burn And Tight LiquidityNegative operating and free cash flow reduce the company’s ability to fund growth, debt obligations, and product investment internally. With only $28 million of cash and approximately $20 million available on its credit facility, sustained underperformance could increase reliance on external financing.
Stressed Balance Sheet And LeverageNegative equity and sizeable debt relative to assets indicate limited financial flexibility and accumulated balance-sheet damage. This structure can raise refinancing and liquidity risk, constrain strategic investment, and leave Cardlytics less able to absorb continued operating losses or revenue volatility.
Cardlytics News
CDLX FAQ
What was Cardlytics Inc’s price range in the past 12 months?
Cardlytics Inc lowest stock price was $1.67 and its highest was $21.70 in the past 12 months.
What is Cardlytics Inc’s market cap?
Cardlytics Inc’s market cap is $10.66M.
When is Cardlytics Inc’s upcoming earnings report date?
Cardlytics Inc’s upcoming earnings report date is Nov 11, 2026 which is in 19 days.
How were Cardlytics Inc’s earnings last quarter?
Cardlytics Inc released its earnings results on Aug 05, 2026. The company reported -$2.58 earnings per share for the quarter, missing the consensus estimate of -$2.3 by -$0.28.
Is Cardlytics Inc overvalued?
According to Wall Street analysts Cardlytics Inc’s price is currently Undervalued.
Does Cardlytics Inc pay dividends?
Cardlytics Inc does not currently pay dividends.
What is Cardlytics Inc’s EPS estimate?
Cardlytics Inc’s EPS estimate is -1.93.
How many shares outstanding does Cardlytics Inc have?
Cardlytics Inc has 5,888,716 shares outstanding.
What happened to Cardlytics Inc’s price movement after its last earnings report?
Cardlytics Inc reported an EPS of -$2.58 in its last earnings report, missing expectations of -$2.3. Following the earnings report the stock price went down -13.936%.
Which hedge fund is a major shareholder of Cardlytics Inc?
Currently, no hedge funds are holding shares in CDLX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cardlytics Inc
Cardlytics, Inc. provides an advertising platform, operating in both the United States and the United Kingdom. Among its key offerings is the Cardlytics platform, a proprietary advertising channel integrated directly into banks' digital environments. This system allows marketers to engage customers through the vast networks of their financial institution partners, leveraging digital avenues such as online portals, mobile applications, email, and various real-time alerts. Furthermore, the company offers the Bridg platform, a comprehensive customer data solution that processes point-of-sale information. This enables marketers to conduct advanced analytics, implement highly targeted loyalty initiatives, and precisely evaluate the performance of their marketing efforts. Cardlytics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
CDLX Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call mixed strong operational and product progress—advertiser expansion, large improvements in churn, meaningful AI-driven efficiency gains, and U.K. momentum—against sizable year-over-year declines in billings and revenue, negative operating and free cash flow, and reduced MQUs driven by prior partner changes. Management emphasized execution, cost discipline, and a path toward self-sustainability, while Q3 guidance is cautious but consistent with stabilization.View all CDLX earnings summariesCDLX Revenue Breakdown
94.25% U.S.
5.75% U.K.
CDLX Stock 12 Month Forecast
Average Price Target
$5.00
▲(21.07% Upside)
Technical Analysis
Ownership Overview
15.71% Insiders
58.06% Mutual Funds
0.35% Other Institutional Investors
21.86% Public Companies and
Individual Investors